{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:44:14Z","timestamp":1785800654562,"version":"3.56.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Princess Beatrix Foundation for Neuromuscular Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.nmd.2026.106468","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T14:31:06Z","timestamp":1780842666000},"page":"106468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1870-3364","authenticated-orcid":false,"given":"Anna","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"van de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Mellion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e8re M.","family":"van der Maarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel G.M.","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20522","article-title":"Facioscapulohumeral muscular dystrophy","volume":"34","author":"Tawil","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106468_bib0002","series-title":"De la myopathie atrophique progressive (myopathie h\u00e9r\u00e9ditaire d\u00e9butant, dans l'enfance, par la face, sans alt\u00e9ration du syst\u00e8me nerveux","author":"Landouzy","year":"1884"},{"key":"10.1016\/j.nmd.2026.106468_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2024.08.007","article-title":"Meryon Lecture St Anne's College, Oxford, 5th July 2024 FSHD: the long road to DUX4","volume":"44","author":"Padberg","year":"2024","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0004","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S0317167100004315","article-title":"Duchenne De Boulogne: a pioneer in neurology and medical photography","volume":"32","author":"Parent","year":"2005","journal-title":"Can J Neurol Sci \/J Can Sci Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.nmd.2026.106468_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12920-019-0488-5","article-title":"Genotype-phenotype correlations in FSHD","volume":"12","author":"Zernov","year":"2019","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.nmd.2026.106468_bib0006","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cge.13446","article-title":"Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1","volume":"94","author":"Mul","year":"2018","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.nmd.2026.106468_bib0007","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"Tawil","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106468_bib0008","first-page":"552","article-title":"Recherches sur La paralysie musculaire pseudohypertrophique, ou paralysie myo-scl\u00e9rosique","volume":"11","author":"Duchenne de Boulogne","year":"1868","journal-title":"Arch G\u00e9n M\u00e9d"},{"key":"10.1016\/j.nmd.2026.106468_bib0009","series-title":"GeneReviews((R))","article-title":"Facioscapulohumeral muscular dystrophy","author":"Preston","year":"1993"},{"issue":"4","key":"10.1016\/j.nmd.2026.106468_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0960-8966(00)00126-7","article-title":"75th European Neuromuscular Centre International Workshop: 2nd Workshop on the treatment of muscular dystrophy 10\u201312 December 1999, Naarden, The Netherlands","volume":"10","author":"Dubowitz","year":"2000","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2026.106468_bib0011","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-32-4-640","article-title":"Studies in disorders of muscle. II clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family","volume":"32","author":"Tyler","year":"1950","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.nmd.2026.106468_bib0012","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.GIM.0000086478.87623.69","article-title":"Penetrance and expressivity in the molecular age","volume":"5","author":"Zlotogora","year":"2003","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2026.106468_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005915","article-title":"A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1","volume":"91","author":"Wohlgemuth","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106468_bib0014","series-title":"Facioscapulohumeral disease","author":"Padberg","year":"1982"},{"key":"10.1016\/j.nmd.2026.106468_bib0015","series-title":"Advances in genetics","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2660(01)42017-7","article-title":"8 The lod score method","author":"Rice","year":"2001"},{"issue":"8716","key":"10.1016\/j.nmd.2026.106468_bib0016","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(90)92148-B","article-title":"Location of facioscapulohumeral muscular dystrophy gene on chromosome 4","volume":"336","author":"Wijmenga","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0017","first-page":"388","article-title":"Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction","volume":"44","author":"Weber","year":"1989","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0018","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1590\/1678-4685-GMB-2016-0027","article-title":"Microsatellite markers: what they mean and why they are so useful","volume":"39","author":"Vieira","year":"2016","journal-title":"Genet Mol Biol"},{"issue":"4","key":"10.1016\/j.nmd.2026.106468_bib0019","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0888-7543(91)90348-I","article-title":"Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization","volume":"9","author":"Wijmenga","year":"1991","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ng0992-26","article-title":"Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy","volume":"2","author":"Wijmenga","year":"1992","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.nmd.2026.106468_bib0021","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","article-title":"FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit","volume":"2","author":"van Deutekom","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.nmd.2026.106468_bib0022","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/hmg\/3.8.1287","article-title":"Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy","volume":"3","author":"Hewitt","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"5\u20136","key":"10.1016\/j.nmd.2026.106468_bib0023","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0960-8966(93)90102-P","article-title":"Molecular genetics of facioscapulohumeral muscular dystrophy","volume":"3","author":"Wijmenga","year":"1993","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0024","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01553323","article-title":"The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease","volume":"2","author":"Winokur","year":"1994","journal-title":"Chromosome Res"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/geno.1995.1166","article-title":"The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes","volume":"28","author":"Lyle","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.nmd.2026.106468_bib0026","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-1119(99)00267-X","article-title":"Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element","volume":"236","author":"Gabriels","year":"1999","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.nmd.2026.106468_bib0027","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/geno.2002.6690","article-title":"Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin","volume":"79","author":"van Geel","year":"2002","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.nmd.2026.106468_bib0028","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ng999","article-title":"Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere","volume":"32","author":"Lemmers","year":"2002","journal-title":"Nat Genet"},{"issue":"7079","key":"10.1016\/j.nmd.2026.106468_bib0029","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04422","article-title":"Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1","volume":"439","author":"Gabellini","year":"2006","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.nmd.2026.106468_bib0030","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/ejhg.2009.62","article-title":"Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level","volume":"17","author":"Klooster","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.nmd.2026.106468_bib0031","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/hmg\/5.10.1567","article-title":"The evolutionary distribution and structural organization of the homeobox-containing repeat D4Z4 indicates a functional role for the ancestral copy in the FSHD region","volume":"5","author":"Winokur","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2026.106468_bib0032","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ng.3844","article-title":"Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons","volume":"49","author":"Hendrickson","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2026.106468_bib0033","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ng.3846","article-title":"Conservation and innovation in the DUX4-family gene network","volume":"49","author":"Whiddon","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2026.106468_bib0034","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3858","article-title":"DUX-family transcription factors regulate zygotic genome activation in placental mammals","author":"De Iaco","year":"2017","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.nmd.2026.106468_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001181","article-title":"Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene","volume":"6","author":"Snider","year":"2010","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.nmd.2026.106468_bib0036","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","article-title":"The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein","volume":"17","author":"Kowaljow","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0037","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.expneurol.2008.07.022","article-title":"DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation","volume":"214","author":"Bosnakovski","year":"2008","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2026.106468_bib0038","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.freeradbiomed.2012.06.041","article-title":"Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction","volume":"53","author":"Turki","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13395-025-00388-0","article-title":"DUX4 at 25: how it emerged from \"junk DNA\" to become the cause of facioscapulohumeral muscular dystrophy","volume":"15","author":"Belayew","year":"2025","journal-title":"Skelet Muscle"},{"issue":"2","key":"10.1016\/j.nmd.2026.106468_bib0041","first-page":"401","article-title":"Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD)","volume":"53","author":"Gilbert","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.nmd.2026.106468_bib0042","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/humu.21091","article-title":"Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD","volume":"30","author":"de Greef","year":"2009","journal-title":"Hum Mutat"},{"issue":"12","key":"10.1016\/j.nmd.2026.106468_bib0043","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.nmd.2026.106468_bib0044","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy","volume":"98","author":"van den Boogaard","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"23","key":"10.1016\/j.nmd.2026.106468_bib0045","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009617","article-title":"Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy","volume":"94","author":"Hamanaka","year":"2020","journal-title":"Neurology"},{"issue":"5999","key":"10.1016\/j.nmd.2026.106468_bib0046","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.nmd.2026.106468_bib0047","doi-asserted-by":"crossref","first-page":"18157","DOI":"10.1073\/pnas.0708659104","article-title":"DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1","volume":"104","author":"Dixit","year":"2007","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0048","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JND-221624","article-title":"Facioscapulohumeral disease as a myodevelopmental disease: applying Ockham's razor to its various features","volume":"10","author":"Padberg","year":"2023","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"10.1016\/j.nmd.2026.106468_bib0049","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2106\/00004623-197860040-00008","article-title":"Scapulocostal stabilization for scapular winging in facioscapulohumeral muscular dystrophy","volume":"60","author":"Ketenjian","year":"1978","journal-title":"JBJS"},{"issue":"5","key":"10.1016\/j.nmd.2026.106468_bib0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mus.880060502","article-title":"Physical models of rehabilitation in neuromuscular disease","volume":"6","author":"Vignos","year":"1983","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2026.106468_bib0051","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1758573219866195","article-title":"Outcomes of scapulothoracic fusion in facioscapulohumeral muscular dystrophy: a systematic review","volume":"12","author":"Kord","year":"2020","journal-title":"Shoulder Elb"},{"issue":"2","key":"10.1016\/j.nmd.2026.106468_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.jse.2025.05.027","article-title":"Outcomes of scapulothoracic fusion using nonabsorbable cerclage tape fixation","volume":"35","author":"Pappas","year":"2026","journal-title":"J Shoulder Elb Surg"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0053","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2106\/JBJS.19.00571","article-title":"Functional outcomes and complications following scapulothoracic arthrodesis in patients with facioscapulohumeral dystrophy","volume":"102","author":"Eren","year":"2020","journal-title":"J Bone Jt Surg Am"},{"issue":"4","key":"10.1016\/j.nmd.2026.106468_bib0054","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ana.410120415","article-title":"Inflammatory facioscapulohumeral muscular dystrophy and Coats syndrome","volume":"12","author":"Wulff","year":"1982","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2026.106468_bib0055","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.50.5.1402","article-title":"Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group","volume":"50","author":"Kissel","year":"1998","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.nmd.2026.106468_bib0056","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","article-title":"Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy","volume":"57","author":"Kissel","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2026.106468_bib0057","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/01.WNL.0000134660.30793.1F","article-title":"Strength training and albuterol in facioscapulohumeral muscular dystrophy","volume":"63","author":"van der Kooi","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nmd.2026.106468_bib0058","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.54.9.1848","article-title":"Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study","volume":"54","author":"Walter","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106468_bib0059","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.48.1.46","article-title":"A pilot trial of prednisone in facioscapulohumeral muscular dystrophy","volume":"48","author":"Tawil","year":"1997","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2026.106468_bib0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","article-title":"A phase I\/IItrial of MYO-029 in adult subjects with muscular dystrophy","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.nmd.2026.106468_bib0061","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.nmd.2006.08.005","article-title":"No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy","volume":"16","author":"van der Kooi","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106468_bib0062","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2014.09.014","article-title":"Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial","volume":"81","author":"Passerieux","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/j.nmd.2026.106468_bib0063","first-page":"15","article-title":"Nutritional status of patients with facioscapulohumeral muscular dystrophy","author":"Amzali","year":"2023","journal-title":"Nutrients"},{"issue":"13","key":"10.1016\/j.nmd.2026.106468_bib0064","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/hmg\/ddp180","article-title":"RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy","volume":"18","author":"Snider","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mt.2015.200","article-title":"CRISPR\/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy","volume":"24","author":"Himeda","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2026.106468_bib0066","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.ymthe.2018.04.019","article-title":"Identification of epigenetic regulators of DUX4-fl for targeted therapy of facioscapulohumeral muscular dystrophy","volume":"26","author":"Himeda","year":"2018","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.nmd.2026.106468_bib0067","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jmedgenet-2019-106402","article-title":"Intronic SMCHD1 variants in FSHD: testing the potential for CRISPR-Cas9 genome editing","volume":"56","author":"Goossens","year":"2019","journal-title":"J Med Genet"},{"issue":"8","key":"10.1016\/j.nmd.2026.106468_bib0068","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.nmd.2017.04.004","article-title":"225th ENMC international workshop:: A global FSHD registry framework, 18\u201320 November 2016, Heemskerk, The Netherlands","volume":"27","author":"Mul","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"20","key":"10.1016\/j.nmd.2026.106468_bib0069","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1212\/WNL.0000000000004647","article-title":"Adding quantitative muscle MRI to the FSHD clinical trial toolbox","volume":"89","author":"Mul","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2026.106468_bib0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JND-230171","article-title":"Facioscapulohumeral muscular dystrophy European Patient Survey: assessing patient reported disease burden and preferences in clinical trial participation","volume":"11","author":"McNiff","year":"2024","journal-title":"J Neuromuscul Dis"},{"issue":"7","key":"10.1016\/j.nmd.2026.106468_bib0071","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.nmd.2023.03.012","article-title":"267th ENMC International workshop: psychological interventions for improving quality of life in slowly progressive neuromuscular disorders","volume":"33","author":"Pater","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"21","key":"10.1016\/j.nmd.2026.106468_bib0072","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0000000000001008","article-title":"Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT","volume":"83","author":"Voet","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0073","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13395-017-0134-x","article-title":"BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells","volume":"7","author":"Campbell","year":"2017","journal-title":"Skelet Muscle"},{"issue":"12","key":"10.1016\/j.nmd.2026.106468_bib0074","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1111\/bcp.14884","article-title":"Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: safety, tolerability, pharmacokinetics, and target engagement","volume":"87","author":"Mellion","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.nmd.2026.106468_bib0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1474-4422(24)00073-5","article-title":"Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial","volume":"23","author":"Tawil","year":"2024","journal-title":"Lancet Neurol"},{"issue":"17_supplement_2","key":"10.1016\/j.nmd.2026.106468_bib0076","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/WNL.0000000000201893","article-title":"Design of REACH: phase 3 randomized, double-blind, placebo-controlled, 48-week study of the efficacy and safety of Losmapimod in FSHD (P6-8.007)","volume":"100","author":"Tawil","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106468_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2025.105422","article-title":"The recent clinical trial of losmapimod for the treatment of facioscapulohumeral muscular dystrophy","volume":"52","author":"Bloch","year":"2025","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106468_bib0078","series-title":"Exploring the role of inflammation in facioscapulohumeral muscular dystrophy","author":"Greco","year":"2025"},{"key":"10.1016\/j.nmd.2026.106468_bib0079","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1016\/j.nmd.2017.06.474","article-title":"ActiMyo home monitoring in adult patients with limb girdle muscular dystrophy type 2B and facioscapulohumeral muscular dystrophy in study ATYR 1940-C-004","volume":"27","author":"Gidaro","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nmd.2022.10.005","article-title":"265th ENMC International Workshop: muscle imaging in Facioscapulohumeral Muscular dystrophy (FSHD): relevance for clinical trials. 22-24 April 2022, Hoofddorp, The Netherlands","volume":"33","author":"Monforte","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106468_bib0081","unstructured":"Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1 (REINFORCE). Available from: https:\/\/clinicaltrials.gov."},{"key":"10.1016\/j.nmd.2026.106468_bib0082","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JND-230063","article-title":"IL-6 and TNF are potential inflammatory biomarkers in facioscapulohumeral muscular dystrophy","volume":"11","author":"Greco","year":"2024","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0083","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JND-210711","article-title":"Identification of serum interleukin 6 levels as a disease severity biomarker in facioscapulohumeral muscular dystrophy","volume":"9","author":"Gros","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106468_bib0084","unstructured":"A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy (MANOEUVRE). Available from: https:\/\/clinicaltrials.gov."},{"key":"10.1016\/j.nmd.2026.106468_bib0085","unstructured":"Clenbuterol to Target DUX4 in FSHD (Target FSHD). Available from: https:\/\/clinicaltrials.gov."},{"key":"10.1016\/j.nmd.2026.106468_bib0086","unstructured":"Phase 1\/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (FORTITUDE). Available from: https:\/\/clinicaltrials.gov."},{"key":"10.1016\/j.nmd.2026.106468_bib0087","unstructured":"Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1. Available from: https:\/\/clinicaltrials.gov)."},{"issue":"9638","key":"10.1016\/j.nmd.2026.106468_bib0088","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(08)61215-5","article-title":"Merging evidence-based and mechanism-based medicine","volume":"372","author":"van der Wilt","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.nmd.2026.106468_bib0089","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1076\/jmep.27.6.651.13793","article-title":"On the triad disease, illness and sickness","volume":"27","author":"Hofmann","year":"2002","journal-title":"J Med Philos"},{"issue":"3","key":"10.1016\/j.nmd.2026.106468_bib0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/22143602241313117","article-title":"The participants' perspective on facioscapulohumeral muscular dystrophy trials in The Netherlands - A qualitative study","volume":"12","author":"Stinissen","year":"2025","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106468_bib0092","unstructured":"FSHD Stichting. Available from: https:\/\/www.fshd.nl\/."},{"issue":"9","key":"10.1016\/j.nmd.2026.106468_bib0098","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1080\/09638288.2022.2066208","article-title":"Development and validation of the patient-reported \"Facial Function Scale\" for facioscapulohumeral muscular dystrophy","volume":"45","author":"Mul","year":"2023","journal-title":"Disabil Rehabil"},{"issue":"12","key":"10.1016\/j.nmd.2026.106468_bib0099","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.nmd.2023.10.020","article-title":"The Dutch registry for facioscapulohumeral muscular dystrophy: cohort profile and longitudinal patient reported outcomes","volume":"33","author":"Kools","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2026.106468_bib0100","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/jcsm.13250","article-title":"Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: the link to clinical outcome","volume":"14","author":"Vincenten","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nmd.2026.106468_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2025.106218","article-title":"Marion or the metamorphosis: a journey of self-reconstruction and hope in the face of FSHD","volume":"55","author":"Sellenet","year":"2025","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0102","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12891-021-04134-7","article-title":"Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.nmd.2026.106468_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2024.02.036","article-title":"The complementary use of muscle ultrasound and MRI in FSHD: early versus later disease stage follow-up","volume":"181","author":"Vincenten","year":"2026","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"10.1016\/j.nmd.2026.106468_bib0104","doi-asserted-by":"crossref","first-page":"fcad221","DOI":"10.1093\/braincomms\/fcad221","article-title":"The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy","volume":"5","author":"Banerji","year":"2023","journal-title":"Brain Commun"},{"issue":"8","key":"10.1016\/j.nmd.2026.106468_bib0105","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70238","article-title":"The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS): longitudinal assessment of a disease-specific patient reported outcome","volume":"32","author":"Teeselink","year":"2025","journal-title":"Eur, J Neurol"},{"issue":"6","key":"10.1016\/j.nmd.2026.106468_bib0106","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/jpm12060865","article-title":"FSHD therapeutic strategies: what will it take to get to clinic?","volume":"12","author":"Himeda","year":"2022","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.nmd.2026.106468_bib0107","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jisesa\/iew092","article-title":"The importance of publishing negative results","volume":"16","author":"Weintraub","year":"2016","journal-title":"J Insect Sci"},{"issue":"18","key":"10.1016\/j.nmd.2026.106468_bib0108","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.3390\/app14188222","article-title":"Therapeutic strategy and clinical path of facioscapulohumeral muscular dystrophy: review of the current literature","volume":"14","author":"Xie","year":"2024","journal-title":"Appl Sci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:51:34Z","timestamp":1785797494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896626001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":102,"alternative-id":["S0960896626001367"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106468","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106468"}}